Cardiomyocyte-specific I?B kinase (IKK)/NF-?B activation induces reversible inflammatory cardiomyopathy and heart failure.
Ontology highlight
ABSTRACT: Inflammation is a major factor in heart disease. I?B kinase (IKK) and its downstream target NF-?B are regulators of inflammation and are activated in cardiac disorders, but their precise contributions and targets are unclear. We analyzed IKK/NF-?B function in the heart by a gain-of-function approach, generating an inducible transgenic mouse model with cardiomyocyte-specific expression of constitutively active IKK2. In adult animals, IKK2 activation led to inflammatory dilated cardiomyopathy and heart failure. Transgenic hearts showed infiltration with CD11b(+) cells, fibrosis, fetal reprogramming, and atrophy of myocytes with strong constitutively active IKK2 expression. Upon transgene inactivation, the disease was reversible even at an advanced stage. IKK-induced cardiomyopathy was dependent on NF-?B activation, as in vivo expression of I?B? superrepressor, an inhibitor of NF-?B, prevented the development of disease. Gene expression and proteomic analyses revealed enhanced expression of inflammatory cytokines, and an IFN type I signature with activation of the IFN-stimulated gene 15 (ISG15) pathway. In that respect, IKK-induced cardiomyopathy resembled Coxsackievirus-induced myocarditis, during which the NF-?B and ISG15 pathways were also activated. Vice versa, in cardiomyocytes lacking the regulatory subunit of IKK (IKK?/NEMO), the induction of ISG15 was attenuated. We conclude that IKK/NF-?B activation in cardiomyocytes is sufficient to cause cardiomyopathy and heart failure by inducing an excessive inflammatory response and myocyte atrophy.
SUBMITTER: Maier HJ
PROVIDER: S-EPMC3406816 | biostudies-other | 2012 Jul
REPOSITORIES: biostudies-other
ACCESS DATA